Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis
- 25 August 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 37 (10), 1605-1612
- https://doi.org/10.1007/s00134-011-2344-8
Abstract
Background Invasive pulmonary aspergillosis (IPA) is a life-threatening infection documented in up to 15% of hematology patients who require intensive care for acute respiratory failure. We report outcomes in hematology patients given mechanical ventilation (MV) with IPA. Methods Retrospective study of all hematology patients given MV with IPA between January 1998 and March 2011 at a single center. Predictors of 6-month survival or mortality were identified using multivariable analysis. Results We studied 67 patients including 49 (73%) with neutropenia, 23 (34%) with long-term steroid therapy, and 14 (21%) with allogeneic bone marrow transplantation. Incidence of IPA in the ICU decreased between 1998 and 2011, and mortality in patients receiving mechanical ventilation did not change. IPA was confirmed in 6 patients by autopsy and was probable in 61 patients based on host factors, clinical and radiographic features, and either Aspergillus isolation (50 patients) or Aspergillus antigen detection alone (11 patients). Concomitant bacterial infections were documented in 24 (36%) patients. ICU and 6-month mortality rates were 67 and 82%, respectively. Mortality was stable throughout the study period. Concomitant bacterial infection was independently associated with higher mortality [HR, 2.1 (1.2–3.8)]. Mortality was lower in patients given voriconazole [OR, 0.5 (0.3–0.9)]. Conclusion Hospital mortality remains high in hematology patients requiring MV with IPA, particularly when concommittant infection occurred. The use of voriconazole improved survival.This publication has 39 references indexed in Scilit:
- Clinical risk factors for invasive aspergillosisMedical Mycology, 2011
- Probable Invasive Aspergillosis without Prespecified Radiologic Findings: Proposal for Inclusion of a New Category of Aspergillosis and Implications for Studying Novel TherapiesClinical Infectious Diseases, 2010
- Diagnostic Strategy for Hematology and Oncology Patients with Acute Respiratory FailureAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer studyBone Marrow Transplantation, 2010
- Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance RegistryClinical Infectious Diseases, 2009
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008
- Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host DiseaseThe New England Journal of Medicine, 2007
- Pulmonary Complications in Adult Blood and Marrow Transplant RecipientsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2005
- The Prognosis of Acute Respiratory Failure in Critically Ill Cancer PatientsMedicine, 2004
- National questionnaire survey on what influences doctors' decisions about admission to intensive careBMJ, 2004